156 related articles for article (PubMed ID: 9333065)
21. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci.
Kaneko A; Sasaki J; Shimadzu M; Kanayama A; Saika T; Kobayashi I
J Antimicrob Chemother; 2000 Jun; 45(6):771-5. PubMed ID: 10837428
[TBL] [Abstract][Full Text] [Related]
22. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
Weigel LM; Anderson GJ; Facklam RR; Tenover FC
Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
[TBL] [Abstract][Full Text] [Related]
23. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
24. gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon.
Salma R; Dabboussi F; Kassaa I; Khudary R; Hamze M
J Infect Chemother; 2013 Feb; 19(1):77-81. PubMed ID: 22821356
[TBL] [Abstract][Full Text] [Related]
25. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the
Nguyen KV; Nguyen TV; Nguyen HTT; Le DV
Infect Drug Resist; 2018; 11():275-282. PubMed ID: 29535543
[TBL] [Abstract][Full Text] [Related]
27. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
28. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
Bachoual R; Ouabdesselam S; Mory F; Lascols C; Soussy CJ; Tankovic J
Microb Drug Resist; 2001; 7(3):257-61. PubMed ID: 11759087
[TBL] [Abstract][Full Text] [Related]
29. Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation.
Gillespie SH; Voelker LL; Ambler JE; Traini C; Dickens A
Microb Drug Resist; 2003; 9(1):17-24. PubMed ID: 12705679
[TBL] [Abstract][Full Text] [Related]
30. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
Shen JL; Zhu DM; Wang MG
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
[TBL] [Abstract][Full Text] [Related]
31. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.
Muñoz R; De La Campa AG
Antimicrob Agents Chemother; 1996 Oct; 40(10):2252-7. PubMed ID: 8891124
[TBL] [Abstract][Full Text] [Related]
32. Role of gyrA mutation and loss of OprF in the multiple antibiotic resistance phenotype of Pseudomonas aeruginosa G49.
Pumbwe L; Everett MJ; Hancock RE; Piddock LJ
FEMS Microbiol Lett; 1996 Sep; 143(1):25-8. PubMed ID: 8807797
[TBL] [Abstract][Full Text] [Related]
33. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
Wong-Beringer A; Wiener-Kronish J; Lynch S; Flanagan J
Clin Microbiol Infect; 2008 Apr; 14(4):330-6. PubMed ID: 18190571
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections.
Teresa Tejedor M; Martín JL; Navia M; Freixes J; Vila J
Vet Microbiol; 2003 Jul; 94(4):295-301. PubMed ID: 12829383
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Jalal S; Ciofu O; Hoiby N; Gotoh N; Wretlind B
Antimicrob Agents Chemother; 2000 Mar; 44(3):710-2. PubMed ID: 10681343
[TBL] [Abstract][Full Text] [Related]
36. Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.
Trong HN; Prunier AL; Leclercq R
Antimicrob Agents Chemother; 2005 May; 49(5):2098-101. PubMed ID: 15855537
[TBL] [Abstract][Full Text] [Related]
37. Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase.
Sekiguchi J; Asagi T; Miyoshi-Akiyama T; Fujino T; Kobayashi I; Morita K; Kikuchi Y; Kuratsuji T; Kirikae T
Antimicrob Agents Chemother; 2005 Sep; 49(9):3734-42. PubMed ID: 16127047
[TBL] [Abstract][Full Text] [Related]
38. Detection of type III secretion system virulence and mutations in gyrA and parC genes among quinolone-resistant strains of Pseudomonas aeruginosa isolated from imported shrimp.
Tran QT; Nawaz MS; Deck J; Foley S; Nguyen K; Cerniglia CE
Foodborne Pathog Dis; 2011 Mar; 8(3):451-3. PubMed ID: 21117986
[TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.
Pletz MW; McGee L; Van Beneden CA; Petit S; Bardsley M; Barlow M; Klugman KP
Antimicrob Agents Chemother; 2006 Mar; 50(3):943-8. PubMed ID: 16495255
[TBL] [Abstract][Full Text] [Related]
40. The roles of mutations in gyrA, parC, and ompK35 in fluoroquinolone resistance in Klebsiella pneumoniae.
Chen FJ; Lauderdale TL; Ho M; Lo HJ
Microb Drug Resist; 2003; 9(3):265-71. PubMed ID: 12959405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
